Company profile
CardioGenics Holdings Inc
OTC: CGNH · Healthcare · Medical - Diagnostics & Research
Canadian filerHQ Mississauga, ONReports USD
#1161 of 1,417 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 35
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ 3-yr revenue growth, return on assets
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.9M
Employees
4
as of 2026-08-29
Market cap
$9.6k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02015
Net income-$1.9M-$1.9M2015
Operating income-$772.1k-$772.1k2015
Total assets$231.9k$231.9k2015
Liabilities$1.8M$1.8M2015
Equity-$1.6M-$1.6M2015
Revenue trend
FY2008 – FY2015 · USD
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is CardioGenics Holdings Inc’s revenue?
CardioGenics Holdings Inc booked $0 in FY2015 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Vaxxinity, Inc.——Thunder Energies Corporation——Eco Science Solutions, Inc.33DManhattan Scientifics, Inc.——VIA Pharmaceuticals, Inc.——OneLife Technologies Corp.——Key facts
CEOYahia Abdul Gawad
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersMississauga, ON
ExchangeOTC: CGNH
Employees4
IPO date2004-06-09
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.